GLP-1 Agonists

Uses

How it works

Benefits

Dosage & preparation

Risks & contraindications

Interactions

Comparisons

Background

Highlighted claims

• Semaglutide is a synthetic analog of the naturally occurring GLP-1 peptide, engineered to block DPP-4 enzymatic degradation and enable once-weekly dosing. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
• Semaglutide commonly causes nausea, vomiting, and muscle loss as side effects. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
• Combining semaglutide with existing insulin therapy can cause dangerous hypoglycemia. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
• Saxenda and Victoza are both liraglutide but have different target doses, titration endpoints, and injection pens, making them a safety-critical distinction especially during drug shortages. — GLP-1 Medications: A Comprehensive Clinical Guide
• GLP-1 receptor agonists originated from research on Gila monster venom, which contained a hormone similar to GLP-1, ultimately leading to the development of exenatide, the first approved agent, in 2005. — GLP-1 Medications: A Comprehensive Clinical Guide
• GLP-1 receptor agonists improve glycemic control and aid weight loss through a multimodal mechanism. — GLP-1 Medications: A Comprehensive Clinical Guide
• GLP-1 medications are classified by peptide backbone — either exendin-4 (derived from Gila monster venom) or human GLP-1. — GLP-1 Medications: A Comprehensive Clinical Guide
• GLP-1 drugs can yield 40-pound weight loss over one year at a cost of roughly $10,000–$12,000. — The Body Composition Trap: Why Conventional Weight Loss Shortens Your Life
• GLP-1 agonists suppress appetite primarily by dampening food-craving signals in the brain and by slowing gastric emptying. — Eight Medications Doctors Fear Most
• Weight loss from GLP-1 therapy includes loss of lean muscle mass, not only fat. — Eight Medications Doctors Fear Most